TRENTON, N.J. (AP) âÄî In a new and disturbing twist on the obesity epidemic, some overweight teenagers have severe liver damage caused by too much body fat, and a handful have needed liver ...
Shares of Sarepta Therapeutics Inc. (NASDAQ:SRPT) plunged to $19.91, down $16.27, or almost 45%, on word of a second death by acute liver failure (ALF) with Elevidys (delandistrogene moxeparvovec), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback